NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Genprex Inc (NASDAQ: GNPX)
GNPX Technical Analysis
5
As on 9th Jun 2023 GNPX STOCK Price closed @ 0.90 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.71 & Strong Sell for SHORT-TERM with Stoploss of 2.05 we also expect STOCK to react on Following IMPORTANT LEVELS. |
GNPXSTOCK Price
Open | 0.92 | Change | Price | % |
High | 0.94 | 1 Day | 0.00 | 0.00 |
Low | 0.90 | 1 Week | 0.10 | 12.50 |
Close | 0.90 | 1 Month | 0.10 | 12.50 |
Volume | 139384 | 1 Year | -0.48 | -34.78 |
52 Week High 3.50 | 52 Week Low 0.76 |
NASDAQ USA Most Active Stocks
TSLA | 244.40 | 4.06% |
TTOO | 0.07 | -12.50% |
SOFI | 8.18 | 0.74% |
FFIE | 0.33 | 6.45% |
PONO | 1.72 | 2.38% |
AMD | 124.92 | 3.20% |
IDEX | 0.06 | 0.00% |
NKLA | 0.70 | 14.75% |
AMZN | 123.43 | -0.66% |
AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
GNPX Daily Charts |
GNPX Intraday Charts |
Whats New @ Bazaartrend |
GNPX Free Analysis |
|
GNPX Important Levels Intraday
RESISTANCE | 0.98 |
RESISTANCE | 0.95 |
RESISTANCE | 0.94 |
RESISTANCE | 0.92 |
SUPPORT | 0.88 |
SUPPORT | 0.86 |
SUPPORT | 0.85 |
SUPPORT | 0.82 |
GNPX Forecast April 2024
4th UP Forecast | 2.85 |
3rd UP Forecast | 2.22 |
2nd UP Forecast | 1.84 |
1st UP Forecast | 1.45 |
1st DOWN Forecast | 0.35 |
2nd DOWN Forecast | -0.04 |
3rd DOWN Forecast | -0.42 |
4th DOWN Forecast | -1.05 |
GNPX Weekly Forecast
4th UP Forecast | 5.62 |
3rd UP Forecast | 4.11 |
2nd UP Forecast | 3.17 |
1st UP Forecast | 2.24 |
1st DOWN Forecast | -0.44 |
2nd DOWN Forecast | -1.37 |
3rd DOWN Forecast | -2.31 |
4th DOWN Forecast | -3.82 |
GNPX Forecast2024
4th UP Forecast | 6.49 |
3rd UP Forecast | 4.7 |
2nd UP Forecast | 3.59 |
1st UP Forecast | 2.48 |
1st DOWN Forecast | -0.68 |
2nd DOWN Forecast | -1.79 |
3rd DOWN Forecast | -2.9 |
4th DOWN Forecast | -4.69 |
Genprex Inc ( NASDAQ USA Symbol : GNPX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
GNPX Other Details
Segment | EQ | |
Market Capital | 109789448.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
GNPX Address
GNPX Latest News
GNPX Business Profile
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes who currently have limited treatment options. The company works with institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. Its lead product candidate is REQORSA (GPX-001), which is in preclinical stage for the treatment of non-small cell lung cancer (NSCLC). It is also developing GPX-002, a preclinical stage gene therapy for diabetes. The company also offers ONCOPREX, a nanoparticle delivery system. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas. Address: 3300 Bee Cave Road, Austin, TX, United States, 78746
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service